Phase 2 Readout~quarter
Phase 2 Readout: bp1.15205
Other upcoming events for HRMY
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Randomized, Double-blind, Placebo-Controlled, Efficacy and Safety Study of HBS-301 in Par
Phase 3 ReadoutPhase 3 Topline: A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole Hydr
Phase 3 ReadoutPhase 3 Topline: Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Clemizole HCl as Adjunctive Thera
Patent ExpiryPatent/Exclusivity Expiry: WAKIX
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.